262 related articles for article (PubMed ID: 23837939)
1. Evaluation of cyclophosphamide pulse therapy as an adjuvant to oral corticosteroid in the management of pemphigus vulgaris.
Sharma VK; Khandpur S
Clin Exp Dermatol; 2013 Aug; 38(6):659-64. PubMed ID: 23837939
[TBL] [Abstract][Full Text] [Related]
2. Randomized open comparative trial of dexamethasone-cyclophosphamide pulse and daily oral cyclophosphamide versus cyclophosphamide pulse and daily oral prednisolone in pemphigus vulgaris.
Sethy PK; Khandpur S; Sharma VK
Indian J Dermatol Venereol Leprol; 2009; 75(5):476-82. PubMed ID: 19736426
[TBL] [Abstract][Full Text] [Related]
3. [Weekly cyclophosphamide pulse therapy combined with corticosteroids in the treatment of pemphigus].
Jia GQ; Chen ZQ; Li HL; Cui PG; Xu WY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Apr; 23(2):173-5. PubMed ID: 12905897
[TBL] [Abstract][Full Text] [Related]
4. [Prolonged complete clinical remission in patients with severe pemphigus vulgaris after cycles of intravenous cyclophosphamide].
España Alonso A; Panizo C; Fernández S; Marquina M; Pretel M; Aguado L; Sánchez-Ibarrola A
Actas Dermosifiliogr; 2009 Mar; 100(2):113-20. PubMed ID: 19445875
[TBL] [Abstract][Full Text] [Related]
5. Corticosteroid/cyclophosphamide pulse treatment in South African patients with pemphigus.
Shaik F; Botha J; Aboobaker J; Mosam A
Clin Exp Dermatol; 2010 Apr; 35(3):245-50. PubMed ID: 19874327
[TBL] [Abstract][Full Text] [Related]
6. Pulsed intravenous cyclophosphamide and methylprednisolone therapy in refractory pemphigus.
Saha M; Powell AM; Bhogal B; Black MM; Groves RW
Br J Dermatol; 2010 Apr; 162(4):790-7. PubMed ID: 19922532
[TBL] [Abstract][Full Text] [Related]
7. The use of oral cyclophosphamide with dexamethasone pulse therapy in the treatment of pemphigus vulgaris.
Momeni AZ; Iraji F; Aminjavaheri M; Emami MR; Momeni A
J Dermatolog Treat; 2007; 18(5):275-8. PubMed ID: 17852639
[TBL] [Abstract][Full Text] [Related]
8. Randomized controlled trial of adjuvant oral dexamethasone pulse therapy in pemphigus vulgaris: PEMPULS trial.
Mentink LF; Mackenzie MW; Tóth GG; Laseur M; Lambert FP; Veeger NJ; Cianchini G; Pavlovic MD; Jonkman MF
Arch Dermatol; 2006 May; 142(5):570-6. PubMed ID: 16702494
[TBL] [Abstract][Full Text] [Related]
9. Cyclophosphamide pulses with oral prednisolone in the treatment of pemphigus: a pilot study.
Bhat R; Sharma VK; Ramam M; Kumar A
Dermatol Online J; 2005 Dec; 11(3):4. PubMed ID: 16409900
[TBL] [Abstract][Full Text] [Related]
10. Assessment of the therapeutic benefit of oral prednisolone and common adjuvant therapy in stage II of randomized controlled trial study for management of pemphigus vulgaris.
Esmaili N; Chams-Davatchi C; Valikhani M; Daneshpazhooh M; Toosi S; Karimi A; Mortazavi H
Arch Iran Med; 2014 Sep; 17(9):626-8. PubMed ID: 25204479
[TBL] [Abstract][Full Text] [Related]
11. Pulse versus oral methylprednisolone therapy in pemphigus vulgaris.
Shahidi-Dadras M; Karami A; Toosy P; Shafiyan A
Arch Iran Med; 2007 Jan; 10(1):1-6. PubMed ID: 17198445
[TBL] [Abstract][Full Text] [Related]
12. Tacrolimus versus intravenous pulse cyclophosphamide therapy in Chinese adults with steroid-resistant idiopathic minimal change nephropathy: a multicenter, open-label, nonrandomized cohort trial.
Li H; Shi X; Shen H; Li X; Wang H; Li H; Xu G; Chen J
Clin Ther; 2012 May; 34(5):1112-20. PubMed ID: 22503105
[TBL] [Abstract][Full Text] [Related]
13. Treatment of pemphigus vulgaris with pulse intravenous cyclophosphamide.
Pandya AG; Sontheimer RD
Arch Dermatol; 1992 Dec; 128(12):1626-30. PubMed ID: 1456758
[TBL] [Abstract][Full Text] [Related]
14. Twelve-year clinico-therapeutic experience in pemphigus: a retrospective study of 54 cases.
Mahajan VK; Sharma NL; Sharma RC; Garg G
Int J Dermatol; 2005 Oct; 44(10):821-7. PubMed ID: 16207182
[TBL] [Abstract][Full Text] [Related]
15. Treatment of Churg-Strauss syndrome without poor-prognosis factors: a multicenter, prospective, randomized, open-label study of seventy-two patients.
Ribi C; Cohen P; Pagnoux C; Mahr A; Arène JP; Lauque D; Puéchal X; Letellier P; Delaval P; Cordier JF; Guillevin L;
Arthritis Rheum; 2008 Feb; 58(2):586-94. PubMed ID: 18240234
[TBL] [Abstract][Full Text] [Related]
16. Long-term efficacy of dexamethasone-cyclophosphamide pulse therapy in pemphigus.
Kanwar AJ; Kaur S; Thami GP
Dermatology; 2002; 204(3):228-31. PubMed ID: 12037452
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of cyclophosphamide, azathioprine, and cyclosporine (ciclosporin) as adjuvant drugs in pemphigus vulgaris.
Olszewska M; Kolacinska-Strasz Z; Sulej J; Labecka H; Cwikla J; Natorska U; Blaszczyk M
Am J Clin Dermatol; 2007; 8(2):85-92. PubMed ID: 17428113
[TBL] [Abstract][Full Text] [Related]
18. Methylprednisolone pulse therapy plus adjuvant therapy for pemphigus vulgaris: an analysis of 10 years' experience on 312 patients.
Gheisari M; Faraji Z; Dadras MS; Nasiri S; Robati RM; Moravvej H; Tehranchinia Z; Ghalamkarpour F; Namazi N; Nobari NN
Dermatol Ther; 2019 Sep; 32(5):e13057. PubMed ID: 31400243
[TBL] [Abstract][Full Text] [Related]
19. Assessment of the therapeutic benefit of dexamethasone cyclophosphamide pulse versus only oral cyclophosphamide in phase II of the dexamethasone cyclophosphamide pulse therapy: a preliminary prospective randomized controlled study.
Parmar NV; Kanwar AJ; Minz RW; Parsad D; Vinay K; Tsuruta D; Ishii N; Hashimoto T
Indian J Dermatol Venereol Leprol; 2013; 79(1):70-6. PubMed ID: 23254732
[TBL] [Abstract][Full Text] [Related]
20. Synchronization of plasmapheresis and pulse cyclophosphamide therapy in pemphigus vulgaris.
Euler HH; Löffler H; Christophers E
Arch Dermatol; 1987 Sep; 123(9):1205-10. PubMed ID: 3632005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
